Provider types explained
Directory resources
Questions to ask
Finding Psychedelic-Informed Healthcare Providers
How to find physicians, therapists, and psychiatrists who understand psychedelic medicine — what they can help with, how to access them, what to ask, and how to recognise red flags in the growing but uneven provider landscape.
This page provides educational guidance on finding healthcare support — not medical advice, and not an endorsement of any specific provider, platform, or directory. Verify all provider credentials independently. Psilocybin is a controlled substance in most jurisdictions.
Psychedelic-informed healthcare providers are more accessible than most people realise. The field has expanded significantly since 2020, telehealth has removed geographic barriers, and the days when every physician would react with alarm to the topic are increasingly behind us. This page is a practical guide to finding the right support — not as a bureaucratic requirement, but as a genuine harm reduction step that meaningfully changes your risk profile.
Why Professional Support Matters for Microdosing
Many people microdose without any professional involvement and do so without incident. But professional support is not just about managing risk — it is about accessing the full potential of the practice. The people who tend to get the most from microdosing are those who approach it as part of a broader health and personal development context, not as an isolated supplement.
What professional support actually provides
A psychedelic-informed physician can evaluate your medication list for interactions, review your health history for contraindications you may not have identified yourself, and give you an honest assessment of whether microdosing is appropriate for your specific situation. This is a one-time consultation in most cases — not an ongoing relationship requirement.
A psychedelic-informed therapist provides something different: a container for the psychological material that microdosing may surface, an outside perspective on changes in your behaviour and mood that your own self-assessment may miss, and a professional relationship that can catch problems before they become crises. For anyone microdosing with therapeutic goals — depression, anxiety, trauma — this is not optional support. It is the difference between using a powerful tool with skilled guidance and using it alone.
WHAT THE EVIDENCE SHOWS ABOUT SUPPORT |
In full-dose psilocybin therapy research, the quality of therapeutic support — preparation, facilitation, and integration — is consistently identified as a stronger predictor of positive outcomes than the dose itself. The mechanism proposed is that psilocybin creates a window of increased psychological openness that professional support helps direct productively. While this finding applies most directly to clinical settings, the same principle extends to microdosing: the supporting context shapes the outcomes.
When professional support is essential, not optional
For people in any of the high-caution categories described in our contraindications guide — bipolar II, severe anxiety, unprocessed trauma, history of addiction, current psychiatric medication — professional involvement is not a suggestion. It is the primary harm reduction step available to you. Self-monitored microdosing without professional support in these populations carries meaningfully higher risk than the same practice with an informed provider in the loop.
🩺
Medical doctor / psychiatrist
Psychedelic-informed physician
Can evaluate medication interactions, order relevant health tests, assess contraindications from a full medical history, and adjust prescriptions where needed. Cannot prescribe psilocybin outside approved clinical settings.
Best for: Medication interactions, contraindication screening, ongoing psychiatric medication management
🌿
Integration coach / guide
Psychedelic integration specialist
Unlicensed practitioners who specialise in preparation and integration support. Quality and training vary widely. Cannot diagnose, prescribe, or practice medicine or therapy. Most appropriate as a complement to, not substitute for, licensed professional care.
Best for: General integration support, journaling guidance, community connection — alongside licensed support
🧠
Licensed therapist / psychologist
Psychedelic-informed therapist
Provides preparation, support, and integration — the psychological container for microdosing practice. Cannot prescribe medications. Training varies significantly; look for specific psychedelic training credentials alongside their licensed clinical qualification.
Best for: Therapeutic goals, integration support, psychological safety monitoring, trauma-informed practice
🔬
Clinical researcher
Psilocybin trial investigator
Physicians and therapists running approved clinical trials of psilocybin for depression, addiction, or other conditions. Can offer access to the substance legally in a clinical setting for qualifying participants.'
Best for: People in hard-contraindication categories who are still interested in psilocybin's therapeutic potential via supervised clinical context
ON INTEGRATION COACHES SPECIFICALLY |
The integration coach category is the least regulated and most variable in quality. Some practitioners in this space have deep training, clinical backgrounds, and genuine expertise. Others have minimal training and market themselves aggressively in a growing commercial space. This category requires the most careful vetting. It should complement licensed professional care, not replace it — particularly for anyone with a complex mental health history.
Directories and Platforms to Find Providers
The following directories and platforms are the most established resources for finding psychedelic-informed providers. None of these are endorsements — they are starting points for your own research. Verify any provider's credentials, licensing, and approach independently before beginning a professional relationship.
Free to search
MAPS Provider Directory
Maintained by the Multidisciplinary Association for Psychedelic Studies. Lists therapists and physicians who have completed MAPS-approved training programmes. One of the most rigorously credentialled directories available.
Therapists
Physicians
USA · Canada · International
Highly vetted
Free to search
Psychedelic Support
One of the largest directories of psychedelic-informed therapists, psychiatrists, and integration specialists. Searchable by location, specialty, and insurance. Also provides educational resources and community.
Therapists
Psychiatrists
USA · Canada · UK · Australia
Integration coaches
Free to search
Zendo Project / MAPS Harm Reduction
Specialises in harm reduction and crisis support for difficult psychedelic experiences. Also maintains a referral network for ongoing integration support. Particularly relevant for anyone who has had a challenging microdosing experience.
Harm reduction focus
Crisis support
Integration referrals
Free to search
Integration Circle
Global directory of integration practitioners with a focus on harm reduction principles. Includes free and sliding-scale providers alongside standard-fee professionals. Useful for those with budget constraints.
Integration specialists
Sliding scale available
Global
Varies
California Institute of Integral Studies (CIIS) Referral Network
CIIS runs one of the most established psychedelic therapy training programmes in the US. Their graduate referral network lists therapists who have completed their clinical training. Particularly strong for California-based providers.
Highly trained therapists
USA focus
Academic credential
Free
ClinicalTrials.gov
The US government registry of all approved clinical trials. Search "psilocybin" to find currently recruiting studies for depression, anxiety, addiction, and other conditions. Participation is free and offers access to supervised psilocybin in a legal, medically monitored setting.
Clinical trials
Free participation
USA · International
For high-caution populations
ON DIRECTORY QUALITY |
Being listed in any directory does not guarantee quality, ethical practice, or appropriate credentials for your specific needs. Use directories as a starting point for finding candidates, not as a vetting system. Verify licensing with your state or country's professional licensing board, ask about specific psychedelic training, and treat the first consultation as a mutual evaluation — you are assessing them as much as they are assessing you.
Telehealth: Removing the Geographic Barrier
Before 2020, finding a psychedelic-informed provider outside major US or European cities was genuinely difficult. Telehealth has fundamentally changed this. A person in a rural area can now access a psychedelic-informed psychiatrist or therapist in their state or country via video consultation — removing the barrier that previously made professional support impractical for most people.
United States
Most accessible region
The largest concentration of psychedelic-informed providers globally, accessible via telehealth across most states. Oregon and Colorado additionally have regulated frameworks for supervised psilocybin services. Search the directories above and filter for telehealth availability.
Canada / UK / Australia
Growing availability
Psychedelic-informed therapists and physicians are increasingly accessible in these markets via telehealth. Canada has a Section 56 exemption process that allows some physicians to prescribe psilocybin for end-of-life distress. The UK and Australia have growing licensed therapist networks.
Europe
Varied by country
The Netherlands has the most accessible legal context (truffles are legal). Switzerland has a small licensed psilocybin therapy programme. Germany and other countries have growing psychedelic-informed therapist communities accessible via telehealth, though supervised psilocybin services remain limited.
WHAT TO EXPECT FROM A TELEHEALTH CONSULATION |
A first consultation with a psychedelic-informed physician or psychiatrist typically involves a full medication review, health history intake, and discussion of your intentions. Many providers offer a 30–60 minute initial consultation at a flat fee. They cannot prescribe psilocybin in most jurisdictions — the value of the consultation is the informed assessment, not a prescription. Come prepared with your full medication list, any relevant diagnosis history, and specific questions about interactions or contraindications in your situation.
Questions to Ask a Potential Provider
The first consultation is a mutual evaluation. These questions help you assess whether a provider has the knowledge, approach, and scope of practice you need — and whether they are the right fit for your specific situation.
1
What is your specific training in psychedelic medicine or psilocybin?
Differentiates providers who completed formal training programmes from those who are self-educated or simply interested in the topic. Look for MAPS, CIIS, IPI, or equivalent programme credentials.
2
Have you worked with other clients who self-administer psilocybin for microdosing?
Many psychedelic-informed providers focus on clinical full-dose therapy rather than self-administered microdosing. This question surfaces whether they have relevant direct experience with your situation.
3
How do you handle medication interactions — specifically, can you review my full list?
This is the primary medical value of the consultation. A provider who cannot or will not review your medications thoroughly is not providing full harm reduction support.
4
What is your approach if I experience a difficult episode or adverse effect?
A good provider should have a clear protocol for crisis support and follow-up. Vague answers here are a yellow flag.
5
Are you willing to communicate with my other healthcare providers if needed?
Coordination between providers matters if you have an existing prescribing physician or therapist. A provider unwilling to communicate with your broader care team creates information silos that increase risk.
6
What are your views on informed consent and autonomy in psychedelic self-use?
This question reveals the provider's philosophical orientation. You want a provider who respects patient autonomy while providing honest safety guidance — not one who either reflexively approves everything or reflexively disapproves self-directed practice.
7
What are your fees, and do you offer sliding scale or reduced rates?
Practical but important. Many psychedelic-informed providers offer sliding scale fees. Telehealth consultations are typically more affordable than in-person. A single medical consultation is often a one-time cost, not an ongoing commitment.
Red Flags to Watch For in the Provider Landscape
The growing commercial interest in psychedelic medicine has attracted a range of practitioners with varying levels of training, ethics, and actual competence. The following table contrasts concerning patterns with more trustworthy ones.
Domain | Red Flag | What to look for instead |
|---|---|---|
Credentials | ⚠ Vague or unverifiable training claims; "certified" by a non-accredited weekend course | ✓ Named training programme (MAPS, CIIS, IPI); verifiable state or national licensure |
Safety approach | ⚠ Promises microdosing is "safe for everyone" or dismisses contraindications without evaluation | ✓ Asks about your full health history and medication list before offering any opinion on suitability |
Scope of practice | ⚠ Unlicensed coach claiming to provide therapy or medical advice; prescribing without a medical licence | ✓ Clear about what they can and cannot do within their scope; refers to licensed professionals when outside their scope |
Financial incentives | ⚠ Pushes specific commercial products, protocols, or retreats; upsells aggressively after initial contact | ✓ Fee-for-service model with clear pricing; no financial relationship with supplement or retreat companies they recommend |
Outcomes framing | ⚠ Makes specific therapeutic outcome claims ("microdosing will cure your depression"); overpromises results | ✓ Evidence-informed, measured in claims; honest about what the research supports and what is uncertain |
Boundaries | ⚠ Suggests dosing together, unusually personal contact, or inappropriate therapeutic boundary violations | ✓ Professional boundaries consistent with licensed clinical practice standards; clear separation of roles |
Legal compliance | ⚠ Offers to source psilocybin or facilitates illegal procurement as part of their service | ✓ Works within the legal framework of their jurisdiction; clearly delineates their role as support, not supply |
Clinical Trials: Accessing Supervised Psilocybin Legally
For people who fall into hard-contraindication categories for self-administered microdosing — or who have treatment-resistant conditions and want the most rigorously supported version of psilocybin therapy available — clinical trial participation is the appropriate pathway. Trials offer legal, medically supervised psilocybin in the context of professional therapeutic support, at no cost to the participant.
1
Search ClinicalTrials.gov using the term "psilocybin" and your condition (depression, anxiety, PTSD, addiction, OCD). Filter by location and recruitment status ("recruiting" means they are currently enrolling participants).
2
Review the eligibility criteria carefully. Most trials have specific inclusion and exclusion criteria — age ranges, diagnosis requirements, medication restrictions. The exclusion criteria often mirror the contraindications covered in this guide series.
3
Contact the trial coordinator listed on the study page. They can answer eligibility questions, describe the protocol in detail, and walk you through the screening process. This contact is free and non-committal.
4
Complete the screening process — typically a phone or video screen, then an in-person clinical assessment. You are not committed to the trial until you sign informed consent, and you can withdraw at any time.
5
Understand what participation involves. Most psilocybin trials involve 2–3 supervised dosing sessions, preparatory meetings beforehand, and integration sessions after. The setting is clinical and supportive. This is fundamentally different from self-administered microdosing — both in intensity and in the depth of professional support available.
WHO THE CLINICAL TRIALS ARE BEST SUITED FOR |
Clinical trials are specifically appropriate for people with treatment-resistant depression, severe anxiety disorders, PTSD, addiction, or other conditions where conventional treatment has been insufficient — and who want access to psilocybin therapy in a medically supervised context. They are also the appropriate pathway for people in hard-contraindication categories for self-administered microdosing who are nonetheless interested in exploring psilocybin's therapeutic potential under proper medical oversight.
Disclosing Microdosing to Your Current Healthcare Provider
Many people worry about disclosing psilocybin use to an existing physician, psychiatrist, or therapist. The concern is understandable — but in most cases, the risks of non-disclosure are greater than the risks of disclosure, and the conversation is often easier than anticipated.
What physicians can and cannot do with this information
In most jurisdictions, physicians are bound by confidentiality and cannot report psilocybin use to law enforcement. Medical records are confidential. Your physician learning that you use psilocybin does not create a legal risk for you in most cases — and even in jurisdictions where psilocybin is illegal, physician confidentiality typically protects this disclosure. The specific legal landscape varies by country and state; if you have specific concerns, consulting a healthcare attorney is the appropriate step, not avoidance.
What non-disclosure costs you
If your physician does not know you are microdosing, they cannot adequately assess medication interactions when making prescribing decisions. If you develop an adverse psychological effect, your providers cannot connect it to the psilocybin use. If you are hospitalised for any reason, the medical team will not have complete information. These gaps in your care record create real, if unlikely, risks that are entirely avoidable through honest disclosure.
How to have the conversation
A straightforward approach works best: "I want to tell you I have been microdosing psilocybin — taking very small sub-perceptual doses on a structured protocol. I wanted to make sure you have the full picture for any prescribing decisions, and I wanted to discuss whether there are any interactions with my current medications I should know about." Most physicians who are reasonably informed will engage with this professionally. Those who react with significant alarm may not be the right provider for your healthcare context — which is itself useful information.
IF YOUR CURRENT PROVIDER IS NOT A GOOD FIT |
If your existing physician or therapist is not a productive conversation partner for this topic — whether because of reflexive moral judgment, unfamiliarity with the research, or an unwillingness to engage — seeking a second opinion from a psychedelic-informed provider is a reasonable and increasingly accessible option. You do not need to leave your existing care relationship; a single consultation with a specialist is sufficient in many cases.
Crisis Resources: When You Need Support Now
If you are experiencing a mental health crisis related to microdosing — or independently of it — the following resources provide immediate support. You do not need to disclose psilocybin use to access any of these services.
📞
988 Suicide & Crisis Lifeline
Free, confidential crisis support 24/7. Available in the United States. Staffed by trained counsellors. Call or text 988. Also available via online chat at 988lifeline.org
Call or text: 988
🌍
Crisis Text Line
Free, confidential text-based crisis support. Available in the US, UK, Canada, and Ireland. Text a trained crisis counsellor from anywhere.
Text HOME to 741741 (US)
🍄
Zendo Project
Specialised harm reduction support for difficult psychedelic experiences. Peer support workers trained in psychedelic crisis response.
Available via phone and online. zendoproject.org
🔥
FIRESIDE Project
Fireside Project is a nonprofit organization that provides free, confidential, and compassionate peer support by phone and text for people undergoing psychedelic experiences. It serves as a crucial harm reduction resource for individuals actively tripping, those trip-sitting, or anyone processing past psychedelic journeys.
Accessible via the mobile app, web, or by calling/texting 62-FIRESIDE (623-473-7433). https://firesideproject.org/
🆘
Local emergency services
If you or someone around you is in immediate physical danger or experiencing a severe psychiatric emergency, call your local emergency number. You do not need to disclose the cause of the crisis.
911 (US) · 999 (UK) · 000 (AU) · 112 (EU)
ON DISCLOSING PSILOCYBIN USE TO CRISIS SERVICES |
If you are in crisis and calling for help, telling the support person or emergency responder that you have taken psilocybin is genuinely important for your safety. It helps them make better decisions about your care — particularly around medication choices if you need emergency psychiatric treatment. The primary concern in a crisis is your safety, not legal consequences. Crisis counsellors are not law enforcement.
FAQ — finding Psychedelic-Informed Providers
Do I need a psychedelic-informed provider to microdose safely?
Not necessarily — many people microdose safely without professional involvement, particularly those who are healthy, unmedicated, and without psychiatric history. However, professional support meaningfully reduces risk and increases the likelihood of positive outcomes. For anyone with a complex health history, current medications, or therapeutic goals, professional support is strongly recommended rather than optional. A single consultation with a psychedelic-informed physician to review your medication list and health history is a low-cost, high-value harm reduction step available to almost everyone.
How much does a consultation with a psychedelic-informed provider cost?
Initial consultations typically range from $100–$300 USD for a 30–60 minute telehealth session with a physician or psychiatrist. Therapists vary more widely — $80–$250 per session is common, with sliding scale options available through many directories. A single physician consultation for medication review is often a one-time cost. Ongoing therapy is a more sustained investment but is also significantly more valuable for people using microdosing for therapeutic purposes.
Will my doctor report me to the police if I tell them I microdose?
In most jurisdictions, no. Physician-patient confidentiality protects disclosures about personal substance use in almost all circumstances. Physicians are not law enforcement and have a professional obligation to maintain confidentiality. Exceptions typically involve imminent danger to self or others — not past or current personal substance use. If you have specific concerns about your jurisdiction, consulting a healthcare attorney before disclosure is a reasonable step, but the legal risk of disclosure to a physician is very low in most countries.
What is the difference between a psychedelic therapist and an integration coach?
A psychedelic therapist is a licensed mental health professional — psychologist, counsellor, social worker, or psychiatrist — with additional training in psychedelic therapy. They can diagnose, treat mental health conditions, and practice within a regulated professional framework with ethical oversight and malpractice accountability. An integration coach is unlicensed, cannot diagnose or treat, and operates outside formal regulatory frameworks. Quality varies enormously. Integration coaches can be valuable for general support but are not a substitute for licensed professional care, particularly for anyone with a complex mental health history.
Can I participate in a psilocybin clinical trial if I don't have a diagnosed condition?
Some trials do recruit healthy volunteers for safety and pharmacology research — these typically study full doses, not microdoses. Therapeutic trials almost always require a specific diagnosis. If you do not have a diagnosed condition but are interested in supervised psilocybin experiences legally, Oregon's regulated psilocybin service framework and similar emerging models in Colorado and internationally are designed for this — they provide licensed facilitated psilocybin sessions outside of a therapeutic or research context.
My therapist doesn't know much about psychedelics — should I find a new one?
Not necessarily. A therapist who is unfamiliar with psychedelic medicine but is open, curious, and willing to engage with what you share from your experience can still be valuable — particularly for integration work. You do not need a specialist for every aspect of the therapeutic relationship. What matters most is that they know you are microdosing, take the practice seriously rather than dismissing it, and can engage with the psychological material that arises during your cycles. A single consultation with a psychedelic-informed specialist to complement your existing therapist relationship is often more practical than switching therapists entirely.
Is it worth paying for a consultation just to confirm my dose and protocol are safe?
If you are unmedicated, have no significant psychiatric history, and have read through this guide series carefully — a formal consultation primarily to confirm dose and protocol is less necessary than for higher-risk individuals. If you take any medications, have any mental health history, or have any conditions mentioned in the contraindications guide, then yes — a single consultation to have a professional eyes on your full picture is genuinely worth the cost. The value is not the validation of your protocol; it is the identification of anything in your specific health context that this guide series cannot account for.
Continue reading
Explore the other cluster pages in this guide series.
How to start microdosing safely — complete guide →
Who should avoid microdosing — contraindications→
Risks and side effects — full guide→
Microdosing for depression — evidence and cautions→
Set and setting — mindset and environment→
Journal guide — tracking your break period→
Medical disclaimer: This guide is for educational and harm reduction purposes only. It does not constitute medical advice. Psilocybin remains a controlled substance in most jurisdictions. Consult a qualified healthcare professional before making any decisions about your health. The authors do not endorse illegal activity of any kind.